Jones Evan/ Fa
CIK: 0001020741
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VERACYTE, INC.
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Jun 11, 2026VCYT
VERACYTE, INC.
Award(A)Direct5.3K shares- - Nov 25, 2025VCYT
VERACYTE, INC.
Sale(S)Direct1.1K shares at avg. $50.25$56K - Nov 5, 2025VCYT
VERACYTE, INC.
Exercise(M)Direct10K shares at avg. $7.94$79K - Nov 5, 2025VCYT
VERACYTE, INC.
Exercise(M)Direct10K shares at avg. $7.60$76K - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct408 shares at avg. $41.74$17K - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct1.1K shares at avg. $43.03$48K - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct5.9K shares at avg. $45.07$265K - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct24.3K shares at avg. $45.73$1.1M - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct657 shares at avg. $46.38$30K - Nov 5, 2025VCYT
VERACYTE, INC.
Sale(S)Direct10.8K shares at avg. $43.80$475K - Nov 5, 2025VCYT
VERACYTE, INC.
Exercise(M)Direct10K shares at avg. $5.28$53K - Jun 18, 2025VCYT
VERACYTE, INC.
Award(A)Direct9.3K shares- - Sep 19, 2024VCYT
VERACYTE, INC.
Sale(S)Indirect5.2K shares at avg. $35.23$182K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | VCYT VERACYTE, INC. | Award(A) | 5,272 | - | $0 | Direct |
| Nov 25, 2025 | VCYT VERACYTE, INC. | Sale(S) | 1,106 | $50.25 | $55,576 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Exercise(M) | 10,000 | $7.94 | $79,400 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Exercise(M) | 10,000 | $7.60 | $76,000 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 408 | $41.74 | $17,031 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 1,126 | $43.03 | $48,455 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 5,872 | $45.07 | $264,640 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 24,296 | $45.73 | $1,110,990 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 657 | $46.38 | $30,469 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Sale(S) | 10,837 | $43.80 | $474,702 | Direct |
| Nov 5, 2025 | VCYT VERACYTE, INC. | Exercise(M) | 10,000 | $5.28 | $52,800 | Direct |
| Jun 18, 2025 | VCYT VERACYTE, INC. | Award(A) | 9,321 | - | - | Direct |
| Sep 19, 2024 | VCYT VERACYTE, INC. | Sale(S) | 5,173 | $35.23 | $182,263 | Indirect |
1-13 of 13 transactions
About JONES EVAN/ FA
JONES EVAN/ FA (SEC CIK 0001020741) files insider reports with the SEC as Director of VERACYTE, INC. (VCYT).
Signal8 holds 5 ownership filings by JONES EVAN/ FA, all Form 4s, filed between Sep 23, 2024 and Jun 15, 2026. Those filings report 13 transactions, from Sep 19, 2024 to Jun 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on JONES EVAN/ FA's filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by JONES EVAN/ FA
- Jun 11, 2026: Grant or award of VCYT shares (Form 4, code A).
- Nov 25, 2025: Open-market sale of VCYT shares (Form 4, code S).
- Nov 5, 2025: Option exercises of VCYT shares (2 lines, Form 4, code M).
- Nov 5, 2025: Open-market sales of VCYT shares (6 lines, Form 4, code S).
- Nov 5, 2025: Option exercise of VCYT shares (Form 4, code M).
Other insiders filing for VERACYTE, INC. (VCYT)
- Wygant Jonathan, VP, Chief Accounting Officer
- Holstein Jens, Director
- EASTHAM KARIN, Director
- Bhanji Muna, Director
- Leite John, Global Chief Commercial Off
- Febbo Phillip G., Chief Scientific & Med Officer